Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,147 | 86,707 | 88,244 | 45,325 | 51,352 |
| Receivables | 49,999 | 50,140 | 30,113 | 49,621 | 27,421 |
| Inventories | 170,235 | 171,801 | 179,810 | 177,732 | 172,906 |
| TOTAL | $331,410 | $318,193 | $303,691 | $276,419 | $257,013 |
| Non-Current Assets | |||||
| PPE Net | 54,707 | 53,694 | 54,326 | 55,317 | 53,835 |
| Intangibles | 3,990 | 4,015 | 4,009 | 3,851 | 4,029 |
| Other Non-Current Assets | 98,571 | 14,716 | 14,373 | 15,288 | 14,305 |
| TOTAL | $157,268 | $72,425 | $72,708 | $74,456 | $72,169 |
| Total Assets | $488,678 | $390,618 | $376,399 | $350,875 | $329,182 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,219 | 16,020 | 14,179 | 17,186 | 15,660 |
| Accrued Expenses | 34,105 | 27,535 | 27,726 | 33,691 | 32,919 |
| TOTAL | $55,542 | $44,891 | $44,177 | $53,088 | $49,806 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,337 | 101,326 | 131,074 | 130,847 | 130,594 |
| Deferred Revenues | N/A | 143 | 1,130 | 1,118 | 182 |
| Other Non-Current Liabilities | 1,673 | 2,063 | 2,078 | 2,093 | 2,107 |
| TOTAL | $84,118 | $113,837 | $143,953 | $144,081 | $144,170 |
| Total Liabilities | $139,660 | $158,728 | $188,130 | $197,169 | $193,976 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 237,615 | 236,390 | 233,083 | 231,809 | 228,220 |
| Common Shares | 24 | 24 | 23 | 23 | 23 |
| Retained earnings | -308,583 | -420,479 | -456,388 | -488,450 | -506,256 |
| TOTAL | $349,018 | $231,890 | $188,269 | $153,706 | $135,206 |
| Total Liabilities And Equity | $488,678 | $390,618 | $376,399 | $350,875 | $329,182 |